Skip to main content

Table 2 Core sets of trial outcome measures

From: Outcome measures in inflammatory rheumatic diseases

Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis
Acute phase reactants Acute phase reactants Acute phase reactants
Swollen joint count Joint counts Joint counts
Tender joint count Axial skeleton Enthesitis
Observer global rating Observer global rating Spinal mobility
Patient global rating Dactylitis Stiffness
Patient pain rating Enthesitis Patient global rating
Physical function Psoriasis extent Patient pain rating
Joint damage by X-ray Nail involvement Physical function
  Patient pain rating  
  Patient itching rating  
  Physical function  
  Joint damage by X-ray  
  1. Trial outcome measures deemed important for disease modifying anti-rheumatic therapies in rheumatoid arthritis [20, 21], psoriatic arthritis [22], and ankylosing spondylitis [23].